Tandem Diabetes Care issued an urgent medical device correction to upgrade the software of its Tandem Mobi insulin pumps that ...
A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.
Before eating a healthy lunch with friends, Megan Fisher, a senior mechanical engineering major, slipped away quietly to check her insulin pump, a tedious chore she must perform before every meal.
(Reuters Health) – - When diabetic patients report problems with their insulin pumps, the pump manufacturers collect that information – but there’s no easy way for researchers to analyze the data ...
Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.
According to the US FDA, at least 224 diabetes patients suffered from injuries linked to a glitch on t:connect iOS which shut down insulin pumps prematurely. isens usa from Unsplash Insulin pumps are ...
A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...
Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...
Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be returned ...
Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them.
All is not well in the land of insulin pumps -- the devices that deliver insulin to mostly Type 1 diabetics -- and the FDA wants to put a spotlight on the problem. Noting that there had been 18 ...
The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses ...